Brazilian Physician Explores Integrated Endoscopic and Injectable Therapies in Obesity Care

Nova Friburgo, Rio de Janeiro Dec 21, 2025 (Issuewire.com) - Flavio Mitidieri Ramos, MD, MSc, Endoscopic Bariatric Specialist and Director of Endodiagnostic, is implementing an integrated approach to obesity care that combines minimally invasive endoscopic bariatric procedures with injectable metabolic therapies as part of a personalized treatment strategy.

This integrated medical model is designed to address both mechanical and metabolic aspects of obesity through individualized clinical planning. Based on observational clinical experience, selected patients undergoing this combined approach have demonstrated meaningful weight reduction over time, along with improvements in metabolic parameters such as glycemic control and overall cardiometabolic health, under strict medical supervision.

Unlike traditional bariatric surgery, endoscopic bariatric procedures do not require surgical incisions and do not permanently alter gastrointestinal anatomy, allowing for faster recovery and broader applicability among patients who may not be candidates for surgical interventions.

Each patient undergoes a comprehensive clinical, metabolic, and behavioral evaluation to determine the most appropriate combination of endoscopic technique and injectable therapy, following evidence-based protocols and the principles of precision medicine.

Flavio Mitidieri Ramos, MD, MSc, is a Brazilian Endoscopic Bariatric Specialist and Director of Endodiagnostic. He is a full member of the Brazilian Society of Digestive Endoscopy (SOBED) and has clinical experience in integrating advanced endoscopic bariatric techniques with injectable metabolic therapies within multidisciplinary obesity care models.

This integrated treatment framework reflects ongoing developments in minimally invasive and metabolic medicine and contributes to the evolving discussion on personalized approaches to obesity management.